SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-005893
Filing Date
2023-03-03
Accepted
2023-03-03 07:31:22
Documents
12
Period of Report
2023-02-27
Items
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11

Document Format Files

Seq Description Document Type Size
1 8-K gls-20230227.htm   iXBRL 8-K 54800
  Complete submission text file 0000950170-23-005893.txt   175143

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gls-20230227.xsd EX-101.SCH 2460
3 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gls-20230227_pre.xml EX-101.PRE 10225
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gls-20230227_lab.xml EX-101.LAB 13904
6 EXTRACTED XBRL INSTANCE DOCUMENT gls-20230227_htm.xml XML 4881
Mailing Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116
Business Address 501 BOYLSTON STREET, SUITE 6102 BOSTON MA 02116 857-327-7737
GELESIS HOLDINGS, INC. (Filer) CIK: 0001805087 (see all company filings)

IRS No.: 844730610 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39362 | Film No.: 23701638
SIC: 2834 Pharmaceutical Preparations